Addressing Unmet Needs in the Management of AML: From Testing to Targeted Therapy

Insights from 2023 ASH Annual Meeting
E

FLT3-ITD Mutated AML: PROs From the QuANTUM-First Trial of Quizartinib vs. Standard Chemo

By Insights from 2023 ASH Annual Meeting FEATURING Esther Oliva
By Insights from 2023 ASH Annual Meeting FEATURING Esther Oliva
153 views
March 22, 2024
Comments 0
Login to view comments. Click here to Login
06:30

EHA 2024 Insights: QuANTUM-First Trial - Newly Diagnosed FLT3-ITD+ A…

Insights from 2024 EHA Annual Meeting

E. Oliva

131 views
23:51

Pre-Transplant Management of High-Risk AML

Vanderbilt University Medical Center (VUMC)

K. Fedorov

101 views
14:58

ASCO® 2024 Summary: "Optimal Treatment Strategies for Younger Patien…

2024 ASCO® Annual Meeting Insights Hub

C. McMahon

292 views
21:05

ASCO® 2024 Summary: "The Art and Science of Caring for Older Adults …

2024 ASCO® Annual Meeting Insights Hub

K. Poh Loh

96 views
35:15

State of the Art and Next Questions: AML

SOHO Highlights: State of the Art and Next Questions

F. Ravandi

388 views
35:08

Experts Discuss the Role of Stem Cell Transplant in AML

MyCancerHaven

R. Vij, M. Qazilbash

114 views
48:04

Integrating Targeted Therapies in AML

Icahn School of Medicine at Mount Sinai

H. Kantarjian

426 views
20:40

What is New in AML: Risk Classification, Germline Mutations, and Tar…

Rush University Medical Center

E. Atallah

238 views
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

408 views
17:01

R/R AML: Current, Emerging, and Targeted Therapies

Indy Hematology Review

R. Komrokji

358 views
17:51

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Indy Hematology Review

H. Erba

932 views
28:02

2024 Updates in AML

University of Colorado Division of Hematology

C. McMahon

770 views
29:38

FLT3-Mutated AML: Advances in Frontline Treatment

Scripps Health

N. Short

249 views
07:56

Role of Mutations in AML: FLT3-ITD Mutation Confers Poor Prognosis b…

University of Miami Sylvester Comprehensive Cancer Center

S. Venugopal

188 views
18:27

FLT3-ITD Mutated AML: QuANTUM-First - Safety by Treatment Phase and …

Insights from 2023 ASH Annual Meeting

H. Erba

208 views
22:30

Emerging Treatment Options for AML in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

A. Perl

732 views
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views
10:32

FLT3-ITD Mutated AML: Quizartinib, Venetoclax, & Decitabine Triple C…

Insights from 2023 ASH Annual Meeting

M. Yilmaz

142 views